|
PER3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.891000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.556800E-01 |
| Normal-vs-Stage2 |
9.221800E-01 |
| Normal-vs-Stage3 |
2.393400E-01 |
| Normal-vs-Stage4 |
5.714400E-01 |
| Stage1-vs-Stage2 |
9.458800E-01 |
| Stage1-vs-Stage3 |
5.857600E-02 |
| Stage1-vs-Stage4 |
4.997800E-01 |
| Stage2-vs-Stage3 |
2.859800E-01 |
| Stage2-vs-Stage4 |
6.363000E-01 |
| Stage3-vs-Stage4 |
6.648200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.035000E-01 |
| Normal-vs-AfricanAmerican |
7.045200E-01 |
| Normal-vs-Asian |
9.492000E-01 |
| Caucasian-vs-AfricanAmerican |
2.739400E-01 |
| Caucasian-vs-Asian |
4.685000E-01 |
| AfricanAmerican-vs-Asian |
6.483400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.042200E-01 |
| Normal-vs-Female |
4.511200E-01 |
| Male-vs-Female |
1.277800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.572400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.042400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.584600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.953200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.040800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.384800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.587800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.996400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.378200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.910800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.861900E-02 |
| Classical-VS-Follicular |
6.530800E-01 |
| Classical-VS-Other |
9.509600E-01 |
| Classical-VS-Normal |
8.462200E-01 |
| Tall-VS-Follicular |
7.218400E-02 |
| Tall-VS-Other |
4.541600E-01 |
| Tall-VS-Normal |
1.633210E-01 |
| Follicular-VS-Other |
8.437800E-01 |
| Follicular-VS-Normal |
8.918800E-01 |
| Other-VS-Normal |
8.983800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.981200E-01 |
| Normal-vs-N1 |
8.179400E-01 |
| N0-vs-N1 |
9.757000E-01 |
|
|
